BeOne Medicines Ltd.

BeOne Medicines is building the world's leading oncology company, driven by scientific excellence and exceptional speed, to reach more patients than ever before. The company operates across six continents, with more than 45 countries and regions running or planning clinical trials, over 190 trials initiated worldwide, and more than 45 global offices. About 12,000 employees work across the globe, including a research team of more than 1,200 people, and more than 30,000 patients have enrolled in its clinical trials. Three internally developed medicines have regulatory approval in more than 80 countries, and BeOne focuses on cancer drug development for cancers with the highest unmet need through an accelerated pipeline.